医学
内科学
心力衰竭
队列
糖尿病
弗雷明翰风险评分
心脏病学
利钠肽
2型糖尿病
疾病
内分泌学
作者
Kershaw V. Patel,Matthew W. Segar,David C. Klonoff,Muhammad Shahzeb Khan,Muhammad Usman,Carolyn S.P. Lam,Subodh Verma,Andrew P. DeFilippis,Khurram Nasir,Stephan J. L. Bakker,B. Daan Westenbrink,Robin P. F. Dullaart,Javed Butler,Muthiah Vaduganathan,Ambarish Pandey
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2023-11-11
卷期号:149 (4): 293-304
被引量:15
标识
DOI:10.1161/circulationaha.123.067530
摘要
The optimal approach to identify individuals with diabetes who are at a high risk for developing heart failure (HF) to inform implementation of preventive therapies is unknown, especially in those without atherosclerotic cardiovascular disease (ASCVD).
科研通智能强力驱动
Strongly Powered by AbleSci AI